Qelbree (Viloxazine ER): Complete Guide to Uses, Dosing, Availability, and How to Find It in Stock

What Is Qelbree?

Qelbree is a brand-name prescription medication containing viloxazine extended-release (ER), a non-stimulant drug used to treat attention-deficit/hyperactivity disorder (ADHD). It belongs to a class called selective norepinephrine reuptake inhibitors (SNRIs), which means it works on brain chemistry without the stimulant properties of medications like Adderall or Ritalin. That distinction matters a lot for patients who haven't tolerated stimulants well, or for families who prefer a non-controlled substance option for their child.

The FDA approved Qelbree in April 2021 for children and adolescents ages 6–17, making it one of the newer ADHD medications on the market. In April 2022, the FDA expanded that approval to include adults, rounding out its use across the full ADHD patient population. Qelbree is manufactured by Supernus Pharmaceuticals and, as of this writing, remains available only as a brand-name product — there is no FDA-approved generic version of viloxazine ER currently on the market, which is a key factor in both its cost and its availability profile.

Because Qelbree is a non-stimulant, it is not classified as a controlled substance by the DEA. That means it doesn't carry the same prescribing restrictions as stimulant ADHD medications, and prescriptions can be called in or sent electronically without the additional DEA-required paper trail. For patients, that often means fewer hoops at the pharmacy — but "fewer hoops" doesn't always mean "easy to find." If you're having trouble finding Qelbree, FindUrMeds can locate it at a pharmacy near you.

How Does Qelbree Work?

Qelbree works by selectively blocking the reuptake of norepinephrine in the brain — a neurotransmitter that plays a central role in attention, focus, and impulse control. In simpler terms: your brain releases norepinephrine to help you concentrate, but it gets recycled back into neurons before it can fully do its job. Viloxazine slows that recycling process, leaving more norepinephrine active in the synaptic space where it's needed. Research also suggests viloxazine modulates serotonin receptors (specifically 5-HT2B and 5-HT7), which may contribute to its effects on mood and executive function — a mechanism that sets it apart slightly from older non-stimulants like Strattera (atomoxetine).

Because it's extended-release, Qelbree is designed to deliver a steady, gradual release of viloxazine over the course of a day. Patients and caregivers typically report noticing initial effects within 1–2 weeks, with full therapeutic benefit often building over 4–6 weeks of consistent use. The capsule's extended-release formulation provides approximately 24 hours of coverage from a single daily dose. Importantly, the capsule can be swallowed whole or opened and sprinkled over a teaspoon of applesauce — a practical feature for pediatric patients or anyone who has difficulty swallowing capsules. It should be taken at the same time each day, and most prescribers recommend morning dosing to minimize any potential impact on sleep.

Available Doses of Qelbree

Qelbree comes in four FDA-approved strengths, all in extended-release capsule form:

100 mg — The standard starting dose for children (ages 6–17) and often for adults. Most prescribers begin here and titrate up based on response and tolerability.
150 mg — A common intermediate step during dose escalation.
200 mg — Another titration option for patients who need more than the starting dose.
400 mg — The maximum approved dose. Used in adults and some adolescents when lower doses haven't achieved adequate symptom control.

For children and adolescents, the recommended starting dose is 100 mg once daily, with the option to increase by 100 mg per week up to a maximum of 400 mg/day. Adult dosing follows a similar ramp-up pattern, also starting at 200 mg once daily in some protocols. Your doctor will determine the right dose for your specific situation — and they may adjust it based on how you respond over the first several weeks.

Having trouble finding a specific dose? FindUrMeds searches all strengths simultaneously.

Qelbree Findability Score

Qelbree Findability Score: 38 / 100

Our Findability Score rates how easy or difficult it is to locate a specific medication in stock at a retail pharmacy, on a scale from 1 to 100. A score of 100 means it's widely available at virtually any pharmacy, any day. A score of 1 means you'll likely need professional help tracking it down. Qelbree's score of 38 puts it in the "moderately difficult" range — not in crisis-level shortage, but reliably frustrating for patients trying to fill it on their own. Based on our data across 15,000+ pharmacy searches, patients seeking Qelbree contact an average of 7–12 pharmacies before finding it in stock.

Several factors drive Qelbree's score. First and most importantly: it remains a brand-only medication with no generic alternative. That means only one manufacturer — Supernus Pharmaceuticals — is producing the drug, and pharmacies must keep it on their shelves as a specialty brand-name product. Retail pharmacies are cautious about over-stocking expensive branded medications with lower turnover than generic ADHD drugs, which means individual store locations often carry only a small quantity at a time. Second, while Qelbree is not on the FDA Drug Shortage Database as a formal shortage (unlike many stimulant ADHD medications), its availability is inconsistent across geographic regions. Our platform's analysis of Qelbree availability found that supply is noticeably tighter in rural zip codes and in pharmacy chains that prioritize high-volume generics over specialty branded medications.

Third, because Qelbree is a non-stimulant, it doesn't face the DEA Schedule II quota restrictions that affect stimulant medications like Adderall. That's a real advantage — but it doesn't solve the distribution problem. Supernus Pharmaceuticals does maintain a consistent manufacturing pipeline, and there are no active FDA alerts about production shortfalls. The challenge is a last-mile distribution issue: the drug exists, but it's spread unevenly across 15,000+ pharmacy locations, and smaller independent pharmacies may not stock it at all.

Practically speaking, this means patients on Qelbree should not assume their usual pharmacy will have it in stock — especially when starting treatment, switching doses, or refilling after any gap. Patients using FindUrMeds for Qelbree report a 91% success rate in locating their prescription within 24–48 hours, compared to an average of 2–3 days of independent calling before giving up or accepting a delay. Skip the pharmacy calls. FindUrMeds finds Qelbree for you.

Qelbree Pricing

Qelbree is a branded medication with no generic equivalent, which puts it firmly in the "specialty pricing" tier. Here's what you can expect depending on your coverage situation:

With Insurance: Most commercial insurance plans that cover Qelbree place it on Tier 3 or Tier 4 of their formulary, which typically translates to a copay of $50–$150 per month for insured patients. Some plans require prior authorization before they'll cover it, especially for adult patients, since Qelbree's adult indication is newer. Your pharmacy benefits manager (PBM) may also require documentation that other ADHD treatments were tried first (step therapy). It's worth calling your insurance before your first fill to understand what's required.

Without Insurance (Cash Price): The list price for Qelbree without any discount is approximately $400–$500 per month depending on the dose. Higher doses (400 mg) cost more than the 100 mg starting dose, since you're using more capsules per fill.

With GoodRx or Similar Discount Cards: GoodRx and similar discount programs can reduce the cash price meaningfully. Estimated GoodRx prices for Qelbree range from approximately $280–$380 per month, with variation depending on the dose and which pharmacy you use. Prices vary by pharmacy and region — in our experience, warehouse clubs like Costco and Sam's Club tend to offer better cash pricing on branded medications than traditional chain pharmacies.

Manufacturer Copay Assistance: Supernus Pharmaceuticals offers a Qelbree Savings Card for eligible commercially insured patients, which can reduce your out-of-pocket cost significantly — in some cases to as low as $0/month depending on your plan. The program is not available to patients on Medicaid, Medicare, or other government-funded insurance. Visit the official Qelbree website or ask your prescriber's office for an enrollment form.

Patient Assistance Programs: Patients without insurance who don't qualify for commercial copay programs may be eligible for Supernus's patient assistance program (PAP), which provides free or reduced-cost medication to qualifying low-income patients. Your prescriber's office can help you apply, or you can inquire directly through the Supernus website.

Who Can Prescribe Qelbree?

Because Qelbree is a non-controlled substance, it has broader prescribing flexibility than stimulant ADHD medications. The following providers can legally prescribe it:

Psychiatrists — The most common prescribers for ADHD in adults; can manage complex cases and co-occurring mental health conditions.
Pediatric psychiatrists — Specialize in ADHD and behavioral health for children and adolescents.
Pediatricians — Many general pediatricians regularly prescribe non-stimulant ADHD medications, particularly for newly diagnosed children.
Primary care physicians (PCPs) and family medicine doctors — Can prescribe for both children and adults, especially for straightforward ADHD cases.
Nurse practitioners (NPs) and physician assistants (PAs) — Can prescribe Qelbree in most states, subject to state-specific scope of practice rules.
Neurologists — Sometimes involved in ADHD treatment, particularly when there are neurological comorbidities.
Developmental pediatricians — Commonly involved in ADHD evaluations and treatment for younger children.

Telemedicine prescribing: Because Qelbree is not a controlled substance, it is not subject to the DEA's Ryan Haight Act restrictions that complicate telehealth prescribing of stimulants. This means a licensed provider can prescribe Qelbree via a telemedicine visit without requiring an in-person evaluation first, subject to state law. Telehealth ADHD platforms like Done, Cerebral, Ahead, and others routinely prescribe non-stimulant medications including Qelbree. This is a meaningful advantage for patients in areas with limited psychiatric access.

Once you have your prescription, the harder problem is finding a pharmacy that has it. That's where FindUrMeds comes in.

Qelbree Side Effects

Qelbree is generally well tolerated, especially compared to stimulant ADHD medications. That said, like any medication, it has a side effect profile worth knowing. Here's what the clinical data — and patient experience — shows.

Most Common Side Effects

These are the side effects reported by at least 5% of patients in clinical trials:

Somnolence / sleepiness — The most frequently reported side effect, particularly early in treatment. Taking Qelbree in the morning and avoiding afternoon dosing can help.
Decreased appetite — Less pronounced than with stimulant medications, but some patients — particularly children — notice reduced hunger, especially around mealtimes.
Nausea — Usually mild and often tied to taking the medication on an empty stomach. Taking Qelbree with food or a small snack can reduce nausea significantly.
Fatigue — Related to somnolence; tends to improve after the first 1–2 weeks as your body adjusts.
Insomnia — Though daytime sleepiness is more common, some patients experience difficulty sleeping, particularly if the dose is taken late in the day.
Irritability — More commonly reported in pediatric patients; often settles as the dose stabilizes.
Headache — Typically mild and transient.
Increased heart rate (tachycardia) — A modest increase in resting heart rate has been observed; your doctor may monitor this, particularly in patients with pre-existing cardiovascular concerns.

Less Common but Serious Side Effects

Contact your provider promptly if you or your child experiences any of the following:

Suicidal thoughts or worsening depression — Like all drugs that affect norepinephrine and serotonin, Qelbree carries an FDA boxed warning for increased risk of suicidal ideation in children, adolescents, and young adults. This is not a reason to avoid the medication, but it does mean caregivers and patients should monitor mood carefully — especially during the first few weeks or after any dose change. Contact your provider immediately if you notice new or worsening depression, agitation, or any thoughts of self-harm.
Elevated blood pressure — Some patients experience meaningful increases in blood pressure. Your doctor will likely check your blood pressure at the start of treatment and periodically during follow-up.
Allergic reactions — Rash, hives, difficulty breathing, or swelling of the face or throat. Seek emergency care immediately.
Liver enzyme elevations — Rare, but viloxazine is metabolized hepatically; patients with liver disease should be monitored more closely.
Mania or hypomania — In patients with undiagnosed bipolar disorder, norepinephrine-active medications can trigger manic episodes.

Side Effects That Typically Improve Over Time

The good news: the most common complaints — nausea, fatigue, and initial sleepiness — are typically at their worst during the first 1–2 weeks of treatment and often resolve substantially as your body adjusts. Most patients who stick with Qelbree through the initial adjustment period report that these early side effects fade significantly.

If side effects feel overwhelming in the first week, let your prescriber know before stopping the medication. There are often simple strategies (adjusting the timing, taking it with food, starting at a lower dose) that make a significant difference.

This information is for general educational purposes and does not replace personalized medical advice. Always discuss side effects with your prescriber or pharmacist.

Alternatives to Qelbree

If Qelbree isn't available, isn't covered by your insurance, or isn't the right fit, there are several alternatives worth knowing about. Your prescriber is the right person to guide this decision — but here's the landscape.

Same-Class Alternatives (Non-Stimulant SNRI/NRI)

Strattera (atomoxetine) — The original non-stimulant ADHD medication; FDA-approved since 2002 and now widely available as a generic, making it significantly more affordable and easier to find. Works through a similar norepinephrine mechanism but has a somewhat different side effect profile and lacks the serotonergic activity of viloxazine.
Generic atomoxetine — Functionally the same as Strattera but at a fraction of the cost; much easier to find at any pharmacy and often under $30/month with GoodRx. This is the most common first alternative when Qelbree is unavailable.

Different-Mechanism Alternatives

For patients who need a different therapeutic approach altogether:

Intuniv (guanfacine ER) / generic guanfacine ER — An alpha-2 agonist, non-stimulant, widely used for ADHD especially in children. FDA-approved for ages 6–17. Tends to be calming and can help with impulsivity and emotional dysregulation.
Kapvay (clonidine ER) / generic clonidine ER — Another alpha-2 agonist, sometimes used as an adjunct or standalone treatment. Often helpful for hyperactivity and sleep.
Adderall (amphetamine salts) — A first-line stimulant for ADHD; highly effective but a Schedule II controlled substance with its own availability challenges.
Vyvanse (lisdexamfetamine) — A prodrug stimulant with a smoother profile than immediate-release amphetamines; now available as a generic.
Ritalin / Concerta (methylphenidate) — Classic stimulant medications; available in many formulations and widely covered by insurance.
Wellbutrin (bupropion) — An antidepressant sometimes used off-label for ADHD in adults; affordable and widely available, though not FDA-approved for ADHD specifically.

If you'd prefer to stick with Qelbree, FindUrMeds has a high success rate finding it in stock.

Drug Interactions with Qelbree

Viloxazine is metabolized primarily by the liver enzyme CYP1A2 and inhibits CYP1A2 itself, which creates a meaningful interaction profile. Always give your pharmacist a complete list of medications, supplements, and substances you're taking.

Serious Interactions

MAOIs (monoamine oxidase inhibitors) — Combining viloxazine with MAOIs (including phenelzine, tranylcypromine, selegiline, or linezolid) can cause a serious, potentially life-threatening interaction similar to serotonin syndrome. Qelbree should not be started within 14 days of stopping an MAOI, and an MAOI should not be started within 7 days of stopping Qelbree.
Sensitive CYP1A2 substrates — Because Qelbree inhibits CYP1A2, it can significantly increase blood levels of medications that are metabolized by this enzyme. The most clinically important example is theophylline (used for asthma/COPD) — combining these can lead to theophylline toxicity. Similarly, certain antipsychotics (clozapine, olanzapine) can have significantly elevated levels when co-administered with Qelbree.

Moderate Interactions

Caffeine — Caffeine is also a CYP1A2 substrate, meaning Qelbree can slow caffeine metabolism and amplify its effects. Patients may feel more stimulated or jittery from their usual coffee intake. This isn't dangerous for most people, but it's worth knowing about.
Other serotonergic medications — SSRIs, SNRIs, triptans, tramadol, and other serotonin-active drugs may have additive effects when combined with Qelbree. Monitor for signs of serotonin syndrome (agitation, rapid heart rate, high fever, muscle twitching).
Antihypertensive medications — Qelbree can modestly raise blood pressure and heart rate; patients on blood pressure medications should be monitored.
CNS depressants — Alcohol, benzodiazepines, and other sedatives may amplify the somnolence associated with Qelbree.

Food and Substance Interactions

Caffeine — As noted above, expect the effects of caffeine to feel stronger than usual. Consider moderating your intake, especially when starting Qelbree or adjusting your dose.
Alcohol — Increases sedation and should be used with caution or avoided, particularly while dose-adjusting.
High-fat meals — Taking Qelbree with a high-fat meal can slightly increase peak plasma concentration and delay the time to peak — not dangerous, but it can affect how the medication feels. Consistent meal habits (always with food, or always without) help keep your response predictable.
Grapefruit juice — No established significant interaction with viloxazine via grapefruit/CYP3A4 pathways; grapefruit is not a major concern with this medication.

How to Find Qelbree in Stock

This is where things get practical. With a Findability Score of 38, Qelbree requires a strategy — not just a walk-in to your nearest CVS. Here's exactly what to do.

1. Use FindUrMeds — The Fastest Route

FindUrMeds was built for exactly this problem. Here's how it works:

You submit your prescription information — tell us the drug, dose, and your zip code. The whole process takes about 2 minutes. No account required, no app to download.
We contact pharmacies on your behalf — our team works the phones across our network of 15,000+ pharmacies, including CVS, Walgreens, Rite Aid, Walmart, Kroger, Publix, Costco, and Sam's Club, to confirm actual stock — not just system inventory, which is often inaccurate.
We send you a match within 24–48 hours — you get a specific pharmacy name, address, and confirmation that your medication is in stock and ready to fill. Our success rate for Qelbree is 91%.

Based on our data across 15,000+ pharmacy searches for Qelbree, patients who call pharmacies themselves contact an average of 7–12 locations before finding stock — often taking 2–3 days or more. FindUrMeds typically resolves the same search in under 48 hours.

2. Use GoodRx to Signal Stock

Here's a trick most patients don't know: GoodRx prices are generated from real-time pharmacy pricing data, and pharmacies that don't carry a drug often don't populate a price. If you pull up Qelbree on GoodRx and search by zip code, locations showing an active price quote are more likely to have the drug in stock. It's not a guarantee — pricing data and inventory data aren't the same thing — but it meaningfully narrows your list before you start calling. Focus on the pharmacies with the most competitive pricing results, as those tend to be the ones actively dispensing the medication.

3. Use Pharmacy Apps and Websites — With Realistic Expectations

CVS, Walgreens, and Walmart all have apps and websites that allow you to check whether a medication is in stock before you transfer your prescription. Here's how to use them effectively:

CVS app — Use "Transfer a Prescription" and enter Qelbree (or viloxazine ER) with your dose. The system will show you which nearby CVS locations list the medication. Call to confirm before transferring, since app inventory lags real-world stock by 12–24 hours.
Walgreens app — Similar functionality. Use "Find a Pharmacy" with your medication name to check stock. Walgreens allows you to narrow by "medications in stock" if you set up a pharmacy profile.
Walmart Pharmacy website — Less robust inventory lookup, but you can use the store finder combined with a call to the pharmacy counter.
Insider tip: Always call to confirm even after a positive app result. Pharmacy inventory systems update on a lag, and a stock indicator on an app doesn't mean the shelf has what you need. Ask specifically: "Is it physically on the shelf right now, and how many units do you have?"

4. Call Using the Generic Name

This one makes a real difference. Many pharmacy staff — especially technicians answering phones — will look up "Qelbree" and come back with "no, we don't have it." But if you ask specifically for viloxazine ER, you may get a more accurate and sometimes more positive result, because the drug may be listed under the generic name in their system even though it's dispensed as a brand.

Phone script — copy this exactly:

"Hi, I'm a patient and I'm trying to fill a prescription. I'm looking for viloxazine extended-release — the brand name is Qelbree. Do you have it in stock in any strength? I'm flexible on the dose if needed. If you don't have it, do you know which nearby locations might?"

That last question is key — pharmacy staff often know which nearby sister locations received a recent shipment and can point you in the right direction without you having to start from scratch.

Ready to stop calling and start filling?

Find Qelbree Near You → findurmeds.com FindUrMeds contacts pharmacies for you. 91% success rate. Results within 24–48 hours.

Frequently Asked Questions

Is Qelbree still in shortage?

As of this writing, Qelbree (viloxazine ER) does not appear on the FDA Drug Shortage Database or the ASHP Drug Shortage Database as a formally declared shortage. That's actually the good news. The challenging news is that Qelbree's availability is inconsistent even without a formal shortage designation — because it's a brand-only medication produced by a single manufacturer, supply at individual pharmacy locations can be unpredictable. Our platform's analysis of Qelbree availability found that roughly 40–55% of retail pharmacy locations carry it in stock on any given week, with significant variation by region and pharmacy chain. Rural areas and smaller independent pharmacies are more likely to be out of stock. If you're repeatedly hitting dead ends, it's not your imagination — the drug is just unevenly distributed.

How much does Qelbree cost without insurance?

Without insurance, Qelbree typically has a list price of approximately $400–$500 per month depending on the dose. With a GoodRx discount card, that can come down to approximately $280–$380 per month at participating pharmacies. If you don't have insurance coverage and can't afford the cash price, Supernus Pharmaceuticals has a patient assistance program for qualifying individuals. Your prescriber's office can help you apply, or you can inquire directly through Supernus. It's also worth asking your prescriber whether generic atomoxetine (generic Strattera) might be an appropriate alternative — it works through a similar mechanism and is available for as little as $15–$30/month with a discount card.

Can I get Qelbree through mail order?

Yes. Because Qelbree is not a controlled substance, it can be dispensed through mail-order pharmacies without any special restrictions. Many insurance plans actually prefer mail-order fills for maintenance medications and may offer a better copay — sometimes a 90-day supply for the cost of a 60-day supply. Major mail-order options include CVS Caremark by Mail, Express Scripts (Cigna), Optum Rx, and Walgreens Mail Service. If your insurer uses one of these, ask about getting a 90-day prescription for Qelbree and enrolling in mail delivery. Turnaround time is typically 7–14 days for the first fill. The advantage: mail-order pharmacies maintain larger inventories of specialty medications and are less likely to run out than your local retail store.

What's the difference between Qelbree and Strattera (atomoxetine)?

Both Qelbree and Strattera are non-stimulant, non-controlled ADHD medications that work primarily by increasing norepinephrine activity in the brain — but they're not identical. Strattera (atomoxetine) has been available since 2002 and is now widely available as an affordable generic. Qelbree (viloxazine ER) was approved in 2021 and is newer, brand-only, and more expensive. Mechanistically, viloxazine also interacts with serotonin receptors (5-HT2B and 5-HT7), which some researchers believe contributes to additional benefits for mood and executive function beyond what atomoxetine provides — though head-to-head comparative trials are limited. In terms of side effects, both can cause nausea, decreased appetite, and fatigue; Strattera carries a stronger association with sexual side effects in adults. Some patients and clinicians choose Qelbree when atomoxetine wasn't tolerated or didn't provide enough benefit. Your prescriber is the best resource for deciding which is right for your specific situation.

What if my pharmacy is out of Qelbree?

First, don't panic — and don't just accept the first "no" as final. Here's your action plan:

Ask the pharmacy if and when they expect a restock — many locations can give you a rough ETA of 3–7 days.
Ask them to order it — pharmacies can usually special-order a brand-name medication if they don't stock it regularly, often within 1–3 business days.
Call other nearby locations — using the phone script above ("Hi, I'm looking for viloxazine ER…"), and try chains you don't normally use.
Use FindUrMeds — our team contacts pharmacies on your behalf across 15,000+ locations and typically finds Qelbree in stock within 24–48 hours.
Talk to your prescriber — if there's going to be an unavoidable delay, your doctor needs to know. They may be able to bridge you with a sample or temporarily adjust your treatment plan.

Do not abruptly stop Qelbree without talking to your prescriber. While it's not a controlled substance with physical withdrawal risks like stimulants, maintaining consistent treatment is important for ADHD management.

Need help finding Qelbree in stock? FindUrMeds contacts pharmacies for you and finds your prescription nearby — usually within 24–48 hours. No more calling around.

Find Qelbree Near You →

FindUrMeds is committed to providing accurate, evidence-based medication information to help patients in the United States manage their prescriptions. This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or pharmacist before making any changes to your medication regimen.

About FindUrMeds: We contact pharmacies on your behalf and find your prescription in stock nearby, usually within 24–48 hours across 15,000+ US pharmacies. Learn how it works →

Qelbree

Findability Score: 40/100